HTA Database - Search Results

Sort by Relevance

Search Results [15895 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2020	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Vascular-targeted photodynamic therapy with padeliporfin (Tookad® Soluble)
2020	National Authority for Assessment and Accreditation in Healthcare (INEAS)	[Statins, lifestyle and dietary interventions to prevent cardiovascular disease]
2020	Adelaide Health Technology Assessment (AHTA)	Discussion paper on pan-tumour biomarker testing to determine eligibility for targeted treatment.
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with yellow fever vaccination
2020	Adelaide Health Technology Assessment (AHTA)	Serious adverse events associated with oral cholera vaccination
2020	NIHR Health Technology Assessment programme	Point-of-care creatinine tests to assess kidney function for outpatients requiring contrast-enhanced CT imaging: systematic reviews and economic evaluation
2020	Swiss Federal Office of Public Health (FOPH)	Glinides and glitazones in the treatment of type 2 diabetes
2020	Health Technology Wales (HTW)	Single-operator per-oral cholangioscopy for the management of hepatobiliary-pancreatic disorders
2020	Health Technology Wales (HTW)	Remote monitoring of blood glucose in women with gestational diabetes
2020	Andalusian Health Technology Assessment Area (AETSA)	Cognitive training effectiveness for mild to moderate dementia patients. A systematic review
2020	Andalusian Health Technology Assessment Area (AETSA)	Genetic risk prediction test for cardiovascular disease
2020	Andalusian Health Technology Assessment Area (AETSA)	Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020	Andalusian Health Technology Assessment Area (AETSA)	Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2020	NIHR Health Technology Assessment programme	Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review
2020	NIHR Health Technology Assessment programme	Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study
2020	Norwegian Institute of Public Health (NIPH)	Abdominal aorta aneurysm (AAA) screening of men aged 65
2020	NIHR Health Technology Assessment programme	Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation
2020	Ontario Health	Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Valve Stenosis at Low Surgical Risk
2020	Ontario Health	Automated CT perfusion imaging to aid in the selection of patients with acute ischemic stroke for mechanical thrombectomy
2020	Ontario Health	Home narrowband ultraviolet B phototherapy for photoresponsive skin conditions
2020	Ontario Health	Noninvasive Fetal RhD Blood Group Genotyping: A Health Technology Assessment
2020	Technology Assessment at SickKids (TASK)	Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020	Norwegian Institute of Public Health (NIPH)	Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2020	Norwegian Institute of Public Health (NIPH)	Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020	Norwegian Institute of Public Health (NIPH)	Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
2020	NIHR Health Technology Assessment programme	Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Endovascular treatment of varicose veins by radiofrequency ablation or cyanoacrylate closure]
2020	NIHR Health Technology Assessment programme	Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis
2020	NIHR Health Services and Delivery Research programme	The effects of interoperable information technology networks on patient safety: a realist synthesis
2020	NIHR Health Services and Delivery Research programme	Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2020	Basque Office for Health Technology Assessment (OSTEBA)	[Clinical Practice Guidelines on the diagnosis and treatment of non-serious blunt chest trauma]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Rapid review: alternatives to timolol for the treatment of glaucoma]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Summary: investigation, treatment and follow-up algorithm - lung cancer]
2020	Scottish Health Technologies Group (SHTG)	Second-generation colon capsule endoscopy (CCE-2) for the detection of colorectal polyps – SHTG Recommendation
2020	Scottish Health Technologies Group (SHTG)	Pre-treatment DPYD genetic testing for patients who are prescribed chemotherapy involving fluoropyrimidines – SHTG Assessment
2020	Scottish Health Technologies Group (SHTG)	Continuous glucose monitoring in pregnant women with type 1 diabetes – SHTG Adaptation
2020	Scottish Health Technologies Group (SHTG)	Endobronchial valves for lung volume reduction in patients with severe or very severe emphysema - SHTG Recommendation
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions, updated in August 2020: administration of drugs prescribed via an individual prescription in the event of distress for a person receiving palliative care]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Home-Treatment in Child and Adolescent Psychiatry: An Analysis of the Effectiveness and Possible Implementation in Austria
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: safety of switching biologics and their interchangeability]
2020	NIHR Health Services and Delivery Research programme	Understanding and improving experiences of care in hospital for people living with dementia, their carers and staff: three systematic reviews
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: update of the systematic review of the effects of palivizumab prophylaxis on reducing complications associated with respiratory syncytial virus infections in children]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Framework for reimbursement decisions of digital health technologies (mHealth) and its (retrospective) application on selected examples
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Effectiveness of Music Therapy for Autism Spectrum Disorder, Dementia, Depression, Insomnia and Schizophrenia
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: iStent® and iStent inject® trabecular bypass for micro-invasive glaucoma surgery (MIGS)]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: prevention of cardiovascular events and safety of SGLT2 inhibitors compared to DPP-4 inhibitors in a real-world setting in patients with type 2 diabetes]
2020	NIHR Health Technology Assessment programme	Cancer diagnostic tools to aid decision-making in primary care: mixed-methods systematic reviews and cost-effectiveness analysis
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of practice: evolving portrait of the use and clinical outcomes of transcatheter aortic valve implantation (TAVI) in Québec, an evaluation in the real-world context of care, 2013 to 2018]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: RebinynTM (nonacog beta pegol) – coagulation factor IX (recombinant), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: recommendations concerning the information required to monitor nusinersen use in real-world settings]
2020	Norwegian Institute of Public Health (NIPH)	[Hyperbaric oxygen therapy for radiation-induced cystitis]
2020	Health Technology Wales (HTW)	Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020	NIHR Health Technology Assessment programme	Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020	Swiss Federal Office of Public Health (FOPH)	Dual antiplatelet therapy following percutaneous coronary intervention
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in hematology]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use of immunoglobulins in clinical immunology]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[State of knowledge: use of sedation and general anesthesia in pediatric dental care]
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Report: the therapeutic value of hyperbaric oxygen (HBO) on children with cerebral palsy]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Genetic testing in the context of familial hypercholesterolaemia management. Organisational and ethical implications (part 1), and economic aspects (part 2)
2020	Austrian Institute for Health Technology Assessment (AIHTA)	[Lung cancer screening in risk groups]
2020	Austrian Institute for Health Technology Assessment (AIHTA)	Lung cancer screening in risk groups: a review-update of the economic evidence (Part II)
2020	Institut national d'excellence en sante et en services sociaux (INESSS)	[Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020	Health Technology Wales (HTW)	Autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis
2020	Health Technology Wales (HTW)	Pre-operative cardiopulmonary exercise testing for people in whom major abdominal surgery is planned
2020	Health Technology Wales (HTW)	Rapid antigen detecting tests for diagnosing group A streptococcal infections in the community pharmacy setting
2020	Health Technology Wales (HTW)	Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2020	Health Technology Wales (HTW)	Point of care haemolysis detection in blood samples that may be deemed unfit for laboratory analysis
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Effectiveness and safety of the left ventricular assist device (LVAD) as destination therapy in paediatric patients]
2020	European Network for Health Technology Assessment (EUnetHTA)	Rolling Collaborative Review COVID-19 - Lopinavir + Ritonavir
2020	Belgian Health Care Knowledge Centre (KCE)	Polyvalent immunoglobulins – Part 2: use in Belgium
2020	Norwegian Institute of Public Health (NIPH)	[Intermittent pneumatic compression for preventing deep vein thrombosis in acute stroke, a health technology assessment]
2020	Norwegian Institute of Public Health (NIPH)	[Effectiveness of microwave thermotherapy (TUMT) compared to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia]
2020	National Committee for Technology Incorporation (CONITEC)	[Dolutegravir for the treatment of pregnant women living with HIV]
2020	National Committee for Technology Incorporation (CONITEC)	[Baricitinib (Olumiant) for patients with moderate to severe active rheumatoid arthritis]
2020	National Committee for Technology Incorporation (CONITEC)	[Mirabegron for the treatment of storage dysfunction in patients with neurogenic bladder]
2020	National Committee for Technology Incorporation (CONITEC)	[Antimuscarinics (oxybutynin, tolterodine, solifenacin and darifenacin) for the treatment of storage dysfunction in patients with neurogenic bladder]
2020	National Committee for Technology Incorporation (CONITEC)	[Photodynamic therapy for non-melanoma skin cancer]
2020	National Committee for Technology Incorporation (CONITEC)	[Newborn screening for congenital toxoplasmosis]
2020	National Committee for Technology Incorporation (CONITEC)	[Riociguat for inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension after surgical treatment]
2020	National Committee for Technology Incorporation (CONITEC)	[Orlistat for weight loss in overweight or obese patients]
2020	National Committee for Technology Incorporation (CONITEC)	[Sibutramine for the treatment of obese patients]
2020	National Committee for Technology Incorporation (CONITEC)	[Empagliflozin and dapagliflozin for the treatment of type 2 diabetes mellitus]
2020	National Committee for Technology Incorporation (CONITEC)	[Rifapentine plus isoniazid for treatment of latent mycobacterium tuberculosis infection (LTBI)]
2020	National Committee for Technology Incorporation (CONITEC)	[Tofacitinib citrate for the treatment of moderate to severe ulcerative colitis in adult patients with inadequate response, loss of response or intolerance to previous treatment with conventional synthetic or biological drugs]
2020	National Committee for Technology Incorporation (CONITEC)	[Expansion of the use of sirolimus for the treatment of adult patients with lymphangioleiomyomatosis]
2020	National Committee for Technology Incorporation (CONITEC)	[Targeted therapies (vemurafenib, dabrafenib, cobimetinib, trametinib) and immunotherapies (ipilimumab, nivolumab, pembrolizumab) for the first-line treatment of advanced (unresectable and metastatic) melanoma]
2020	National Committee for Technology Incorporation (CONITEC)	[Personal frequency modulation system for hearing-impaired students at any age and at any academic level]
2020	National Committee for Technology Incorporation (CONITEC)	[Cytoreductive surgery with hyperthermic chemotherapy in patients with malignant peritoneal mesothelioma]
2020	National Committee for Technology Incorporation (CONITEC)	[Cytoreductive surgery (peritonectomy) with hyperthermic intraperitoneal chemotherapy (HIPEC)]
2020	National Committee for Technology Incorporation (CONITEC)	[Exclusion of rifampicin for chemoprophylaxis for contacts of patients with Hansen´s disease]
2020	National Committee for Technology Incorporation (CONITEC)	[Ruxolitinib for the treatment of patients with primary myelofibrosis, post-polycythaemia vera myelofibrosis or post-essential thrombocythaemia myelofibrosis, in people with intermediate-2 or high-risk disease]
2020	Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)	[Comparative results of the different screening strategies used for T21, T18 and T13: adaptation of the EUnetHTA assessment]
2020	The National Health Care Institute (ZIN, Zorginstituut Nederland)	Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors
2020	Penn Medicine Center for Evidence-based Practice (CEP)	Adverse effects of messenger RNA vaccines